![Douglas Love](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas Love
Chief Executive Officer at ANNEXON, INC.
Net worth: 882 861 $ as of 2024-05-30
Profile
Douglas Love's current job(s) include being the President, Chief Executive Officer & Director at Annexon, Inc. since 2014 and also holding the same titles at Annexon Biosciences, Inc.Mr. Love's former job(s) include working as a Corporate Counsel at Amgen, Inc. from 1999 to 2001, as a Corporate Counsel at Genentech, Inc. from 2001 to 2006, as the Head-Operations & Strategic Alliances at Elan Pharmaceuticals LLC from 2008 to 2013, and as an Associate at Orrick, Herrington & Sutcliffe LLP from 1996 to 1999.
Mr. Love completed his undergraduate degree at the University of Southern California in 1991 and obtained his graduate degree from Mcgeorge School of Law in 1995.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ANNEXON, INC.
0.20% | 2024-02-29 | 182,787 ( 0.20% ) | 882 861 $ | 2024-05-30 |
Douglas Love active positions
Companies | Position | Start |
---|---|---|
ANNEXON, INC. | Chief Executive Officer | 2014-11-30 |
Annexon Biosciences, Inc. | Chief Executive Officer | - |
Former positions of Douglas Love
Companies | Position | End |
---|---|---|
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2013-03-31 |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | General Counsel | 2005-12-31 |
AMGEN INC. | General Counsel | 2000-12-31 |
Orrick, Herrington & Sutcliffe LLP
![]() Orrick, Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Orrick, Herrington & Sutcliffe LLP engages in the provision of legal services. Its practices include: antitrust and competition; banking and finance; capital markets; copyright, trademark and false advertising; cyber, privacy and data innovation; employment law and litigation; energy; financial services litigation; global compliance and regulatory, infrastructure; intellectual property; patents; public finance; real estate; securities litigation; supreme court and appellate; tax advocacy; technology transactions; trials; and white collar, investigations, securities litigation and compliance. The company was founded by John R. Garboe in 1863 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 1998-12-31 |
Training of Douglas Love
Mcgeorge School of Law | Graduate Degree |
University of Southern California | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ANNEXON, INC. | Health Technology |
AMGEN INC. | Health Technology |
Private companies | 4 |
---|---|
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Orrick, Herrington & Sutcliffe LLP
![]() Orrick, Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Orrick, Herrington & Sutcliffe LLP engages in the provision of legal services. Its practices include: antitrust and competition; banking and finance; capital markets; copyright, trademark and false advertising; cyber, privacy and data innovation; employment law and litigation; energy; financial services litigation; global compliance and regulatory, infrastructure; intellectual property; patents; public finance; real estate; securities litigation; supreme court and appellate; tax advocacy; technology transactions; trials; and white collar, investigations, securities litigation and compliance. The company was founded by John R. Garboe in 1863 and is headquartered in San Francisco, CA. | Commercial Services |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Annexon Biosciences, Inc. |
- Stock Market
- Insiders
- Douglas Love